KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors

NCT02250885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Neuroendocrine

Interventions

DRUG: Selinexor

Sponsor

Gabrail Cancer Center Research

Collaborators

[object Object]